Clinical Trial Update: Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma [NA]

View source ↗

Summary

This completed clinical trial examines recurrent XPO1 mutations and their prognostic value in patients with Classical Hodgkin Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Classical Hodgkin Lymphoma | NA | Status: COMPLETED